OR WAIT null SECS
Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.
July 02, 2020
Controlled-release formulations offer numerous advantages for developers and patients, and this market is expected to continue to experience growth in the near future.
COVID-19 vaccines are being developed rapidly, giving rise to a reinvigoration of the sector.
As Brexit talks intensify, bio/pharma companies from both the UK and EU need to consider and aim to prepare for all scenarios.
June 25, 2020
The importance of capability and capacity of a CDMO partner to deliver drug substance and product testing should never be underestimated, considering the increasing complexity of compounds in development.
June 02, 2020
Increasing prevalence of drug misuse and abuse is driving a heightened and more stringent approach to abuse-deterrent formulations.
Connected delivery solutions can provide value to industry and patients, through improved medication adherence and outcome optimization.